Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in oncology, women's health, and organ health. The company aims to integrate personalized genetic testing into the standard of care, enabling earlier diagnoses and targeted interventions that contribute to improved health outcomes. Natera draws on a diverse team of experts, including geneticists, laboratory scientists, and software engineers, who collaborate to advance the field of genetic disease management. By focusing on innovation and research, Natera seeks to expand the potential of genetic diagnostics for both patients and healthcare professionals. The company prides itself on maintaining a commitment to diversity and inclusion, recognizing that a variety of perspectives strengthens its mission to transform healthcare and improve lives worldwide.